Mohkum Sethi
About Mohkum Sethi
Mohkum Sethi is an Associate Process Engineer I at Bristol Myers Squibb, specializing in CAR-T Manufacturing Science & Technology. He has prior experience in brand protection, spray technology, and community advocacy.
Current Position at Bristol Myers Squibb
Mohkum Sethi currently holds the position of Associate Process Engineer I at Bristol Myers Squibb. He is part of the aCTivate Associate program, focusing on CAR-T Manufacturing Science & Technology. He is based in Summit, New Jersey, United States and has been working on projects related to CAR-T Manufacturing Science & Technology since June 2021. The aCTivate program is dedicated to advancing CAR-T cell therapy manufacturing, which is a specialized area in the pharmaceutical industry.
Previous Experience at Johnson & Johnson
Mohkum Sethi worked at Johnson & Johnson in 2019 as a Global Brand Protection Co-op. During his 7-month tenure in Raritan, New Jersey, he gained valuable experience in the brand protection domain. This role involved ensuring product integrity and combating counterfeiting, thus contributing to the safeguarding of Johnson & Johnson's global brand.
Co-op Position at Avon Products
In 2018, Mohkum Sethi held a position as a Spray Technology Co-op at Avon Products for 7 months. Based in Suffern, New York, he worked on various aspects of spray technology. This role enriched his knowledge and skills in the consumer goods industry, specifically focusing on product formulations and delivery mechanisms.
Volunteer Work with The Sikh Coalition
From 2017 to 2018, Mohkum Sethi served as a Volunteer Advocate with The Sikh Coalition in the Washington D.C. Metro Area. During this one-year period, he contributed to community advocacy efforts, working towards the empowerment and protection of the Sikh community. His role involved community outreach and advocacy initiatives.
Education at Stevens Institute of Technology
Mohkum Sethi earned a Bachelor of Engineering (BE) degree in Chemical Engineering from Stevens Institute of Technology. He attended the institution from 2016 to 2021. His engineering education provided a strong foundation in chemical processes and technology, underpinning his subsequent professional work in engineering and pharmaceutical manufacturing.